𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of the Inhibition of Cyclooxygenase-2 on Human Esophageal Cancer Cells: Inhibition of Cell Proliferation and Induction of Apoptosis

✍ Scribed by Li Zhang; Jun Tu; Zhong-lin Yu; Yong-dong Wu; Cai-min Xu; Shu-tian Zhang


Publisher
Springer Netherlands
Year
2009
Tongue
English
Weight
187 KB
Volume
16
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Selective inhibition of cyclooxygenase (
✍ Kentaro Yazawa; Nelson H. Tsuno; Joji Kitayama; Kazushige Kawai; Yurai Okaji; Ma πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 336 KB

High-level expression of cyclooxygenase (COX)-2 is reported in 80 -90% of colorectal adenocarcinomas. Selective inhibition of COX-2 was shown to reduce colorectal tumorigenesis in different models of carcinogenesis and to prevent metastasis in xenograft tumor models, as well as to suppress in vitro

Rapamycin potentiates the effects of pac
✍ Aaron Shafer; Chunxiao Zhou; Paola A. Gehrig; John F. Boggess; Victoria L. Bae-J πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 747 KB

## Abstract Mammalian target of rapamycin (mTOR) inhibitors modulate signaling pathways involved in cell cycle progression, and recent phase II trials demonstrate activity in patients with endometrial cancer. Our objective was to examine the effects of combination therapy with rapamycin and paclita

Inhibition of cell proliferation and ind
✍ Eddi Di Marco; Nadia Sessarego; Barbara Zerega; Ranieri Cancedda; Fiorella Desca πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 363 KB

## Abstract Ex‐FABP, an extracellular fatty acid binding lipocalin, is physiologically expressed by differentiating chicken chondrocytes and myoblasts. Its expression is enhanced after cell treatment with inflammatory stimuli and repressed by anti‐inflammatory agents, behaving as an acute phase pro

Inhibition of survivin reduces cell prol
✍ Zhihong Ai; Lianhua Yin; Xianrong Zhou; Ying Zhu; Dongmei Zhu; Yinhua Yu; Youji πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 765 KB

## Abstract ## BACKGROUND Endometrial cancer is a common gynecologic malignancy among women. The molecular mechanisms involved in the progression of endometrial cancer are unclear, which has hampered the development of an effective treatment. Survivin, a newly identified member of the inhibitor of